At the time of writing, Assembly Biosciences Inc [ASMB] stock is trading at $24.7, down -3.14%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ASMB shares have lost -8.28% over the last week, with a monthly amount glided 37.80%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Guggenheim started tracking the stock with Buy rating on March 25, 2025, and set its price target to $31. On September 20, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $35 on the stock. H.C. Wainwright started tracking the stock assigning a Neutral rating and suggested a price target of $3.50 on September 13, 2021. William Blair downgraded its rating to a Mkt Perform. SVB Leerink downgraded its rating to Mkt Perform for this stock on March 23, 2021. In a note dated November 06, 2020, Jefferies downgraded an Hold rating on this stock and revised its target price from $30 to $10.
For the past year, the stock price of Assembly Biosciences Inc fluctuated between $7.75 and $27.17. Currently, Wall Street analysts expect the stock to reach $35.5 within the next 12 months. Assembly Biosciences Inc [NASDAQ: ASMB] shares were valued at $24.7 at the most recent close of the market. An investor can expect a potential return of 43.72% based on the average ASMB price forecast.
Analyzing the ASMB fundamentals
According to Assembly Biosciences Inc [NASDAQ:ASMB], the company’s sales were 33.25M for trailing twelve months, which represents an 12.81% jump. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -1.84%, Pretax Profit Margin comes in at -1.65%, and Net Profit Margin reading is -1.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -1.49 and Total Capital is -1.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.99 points at the first support level, and at 23.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.42, and for the 2nd resistance point, it is at 26.14.
Ratios To Look Out For
It is important to note that Assembly Biosciences Inc [NASDAQ:ASMB] has a current ratio of 1.64. As well, the Quick Ratio is 1.64, while the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 9.85, the price to book ratio is 10.47.
Transactions by insiders
Recent insider trading involved McHutchison John G, Director, that happened on Mar 31 ’25 when 757.0 shares were sold. Principal Accounting Officer, Bjorkquist Jeanette M completed a deal on Mar 31 ’25 to sell 180.0 shares. Meanwhile, CEO and President Okazaki Jason A sold 355.0 shares on Mar 31 ’25.
